SecBot SecBot
8-K ·Filed Jun 1, 2026

CYH

COMMUNITY HEALTH SYSTEMS INC
NEUTRAL
Impact 5/10
Horizonweeks Processed5mo ago SEC0001193125-26-251540
8-K material event: Items 2.01
Actionable Insight • Neutral

The divestiture is a modest deleveraging event that provides ~$107M in net cash proceeds, but the $55M pre-tax loss on sale and loss of $415M in annual revenue (~3.3% of total) suggest the assets were sold at a discount to carrying value. Monitor the post-closing working capital adjustment for potential further cash impact. The sale reduces CYH's geographic footprint but does not materially change the company's leverage profile (pro forma long-term debt remains $10.127B). Watch for additional hospital divestitures as CYH continues its portfolio rationalization strategy.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$2.78
T+0 close · Jun 1, 2026 · via day close
Latest settled
+5.04%
T+60 · $2.92
Vs SPY
+3.92%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $2.78entry
  2. T+1 · 6mo ago +0.72%α +1.44% · $2.80
  3. T+5 · 5mo ago +3.24%α +6.20% · $2.87
  4. T+20 · 5mo ago +27.34%α +28.90% · $3.54
  5. T+60 · 3mo ago +5.04%α +3.92% · $2.92

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Community Health Systems (CYH) completed the sale of four Arkansas hospitals (Northwest Medical Center - Bentonville, Northwest Medical Center - Springdale, Northwest Medical Center - Willow Creek Women's Hospital, and Siloam Springs Regional Hospital) and associated outpatient centers to Freeman Health System for $110 million in cash, subject to post-closing working capital adjustments. The transaction resulted in a pro forma pre-tax loss on sale of $55 million ($48 million after tax), and the divested operations generated approximately $415 million in annual revenue (3.3% of CYH's 2025 total revenue of $12.485 billion). The sale reduces CYH's hospital count from 64 to 60 affiliated hospitals and provides cash proceeds of ~$107 million net of transaction expenses, which will increase cash and cash equivalents to approximately $819 million on a pro forma basis.

Key Facts

  • Completed sale of 4 Arkansas hospitals to Freeman Health System for $110 million in cash
  • Purchase price after estimated working capital and finance lease assumption was $110 million, subject to post-closing adjustment
  • Pro forma pre-tax loss on sale of $55 million ($48 million after tax)
  • Divested operations generated ~$415 million in annual revenue (3.3% of CYH's total 2025 revenue of $12.485 billion)
  • Net cash proceeds of ~$107 million after $3 million in transaction expenses
  • Pro forma cash and cash equivalents increase to ~$819 million from $712 million
  • CYH retains 60 affiliated hospitals post-divestiture (down from 64)
  • Seller provided $78,614 credit for chiller repairs and $500,000 credit for environmental matters
  • 3-year non-compete covenant within 40-mile radius of the hospitals
  • Transition services agreements for IT, billing, and clinical operations post-closing

Financial Impact

Sale proceeds of $110 million cash; pro forma loss on sale of $55 million pre-tax ($48 million after tax); divested revenue of ~$415 million annually (3.3% of total); cash balance increases by ~$107 million net

revenuecashoperating incomeasset basehospital count

Risk Factors

  • Post-closing working capital adjustment could reduce net proceeds
  • Loss of $415M in annual revenue may pressure future earnings comparisons
  • Retained liabilities for pre-closing operations (medical malpractice, regulatory, tax) could result in future cash outflows
  • Transition services agreements create operational complexity and potential disputes
  • Environmental credits ($500K) may not fully cover remediation costs

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
13% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-251540
Document: cyh-ex99_1.htm0001193125-26-251540
Document: cyh-20260601.htm0001193125-26-251540
Document: cyh-ex99_2.htm0001193125-26-251540
Document: 0001193125-26-251540-index-headers.html0001193125-26-251540
Document: 0001193125-26-251540-index.html0001193125-26-251540
Document: 0001193125-26-251540.txt0001193125-26-251540

Track record

5 reports on CYH

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $2.17 Now $2.13 −1.84% settles Nov 17
  2. Oct 28, 202619d ago 8-K Bearish 6/10 Entry $2.41 to $2.28 Now $2.13 +11.62% ▲ +5.39% +0.67% vs SPY
  3. Jun 1, 202624w ago 8-K Neutral 5/10 Viewing Entry $2.78 to $2.87 Now $2.13 −23.38% ▲ +3.24% +6.20% vs SPY
  4. Apr 21, 202629w ago 8-K Bearish 7/10 Entry $2.71 to $2.87 Now $2.13 +21.40% ▼ −5.90% −5.85% vs SPY
  5. Mar 5, 202636w ago 8-K Neutral 5/10 Entry $3.35 to $3.20 Now $2.13 −36.42% ▼ −4.48% −2.95% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens in 7h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026